{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:13:04Z","timestamp":1755216784933,"version":"3.43.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ogc.2025.05.004","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T23:42:26Z","timestamp":1749771746000},"page":"519-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sickle Cell Disease and Other Causes of Anemia"],"prefix":"10.1016","volume":"52","author":[{"given":"Raina A.","family":"Meka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda C.","family":"Zofkie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannie C.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4 Suppl","key":"10.1016\/j.ogc.2025.05.004_bib1","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"1","key":"10.1016\/j.ogc.2025.05.004_bib2","first-page":"4","article-title":"Differences in the clinical and genotypic presentation of sickle cell disease around the world","volume":"15","author":"Saraf","year":"2014","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.ogc.2025.05.004_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-3-030-41769-7_12","article-title":"Sickle cell hemoglobin","volume":"94","author":"Mandal","year":"2020","journal-title":"Subcell Biochem"},{"issue":"16","key":"10.1016\/j.ogc.2025.05.004_bib4","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2025.05.004_bib5","first-page":"1","article-title":"Complications of sickle cell disease and current management approaches","volume":"10","author":"Martinez","year":"2020","journal-title":"Addressing Sickle Cell Disease"},{"issue":"4","key":"10.1016\/j.ogc.2025.05.004_bib6","doi-asserted-by":"crossref","first-page":"505.e1","DOI":"10.1016\/j.ajog.2016.05.032","article-title":"Contemporary outcomes of sickle cell disease in pregnancy","volume":"215","author":"Kuo","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"21","key":"10.1016\/j.ogc.2025.05.004_bib7","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2014-11-607317","article-title":"Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis","volume":"125","author":"Oteng-Ntim","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ogc.2025.05.004_bib8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/hematology.2022000376","article-title":"Acute pain episodes, acute chest syndrome, and pulmonary thromboembolism in pregnancy","volume":"2022","author":"Asare","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"10.1016\/j.ogc.2025.05.004_bib9","doi-asserted-by":"crossref","first-page":"125.e1","DOI":"10.1016\/j.ajog.2008.04.016","article-title":"Morbidity associated with sickle cell disease in pregnancy","volume":"199","author":"Villers","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2025.05.004_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/AOG.0000000000004478","article-title":"Anemia in pregnancy: ACOG practice bulletin summary, number 233","volume":"138","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2025.05.004_bib12","doi-asserted-by":"crossref","first-page":"B17","DOI":"10.1016\/j.ajog.2023.10.031","article-title":"Society for maternal-fetal medicine consult series #68: sickle cell disease in pregnancy","volume":"230","author":"Sinkey","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2025.05.004_bib13","doi-asserted-by":"crossref","unstructured":"Oteng -Ntim E and Shangaris P, Evidence-based management of pregnant women with sickle cell disease in high-income countries, Available at: http:\/\/ashpublications.org\/hematology\/article-pdf\/2022\/1\/408\/2022826\/408otengntim.pdf (Accessed 10 November 2024).","DOI":"10.1182\/hematology.2022000378"},{"issue":"8","key":"10.1016\/j.ogc.2025.05.004_bib14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/papr.12814","article-title":"Medication use and pain management in pregnancy: a critical review","volume":"19","author":"Black","year":"2019","journal-title":"Pain Pract"},{"issue":"1","key":"10.1016\/j.ogc.2025.05.004_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/(SICI)1096-8652(199901)60:1<24::AID-AJH5>3.0.CO;2-C","article-title":"Deferoxamine treatment during pregnancy: is it harmful?","volume":"60","author":"Singer","year":"1999","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.ogc.2025.05.004_bib16","first-page":"251","article-title":"The consequences of iron overdose and its treatment with desferrioxamine in pregnancy","volume":"10","author":"McElhatton","year":"1991"},{"issue":"20","key":"10.1016\/j.ogc.2025.05.004_bib17","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ogc.2025.05.004_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2022.10233","article-title":"Sickle cell disease: a review","volume":"328","author":"Kavanagh","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2025.05.004_bib19","unstructured":"Chaube S and Murphy ML, The effects of hydroxyurea and related compounds on the rat fetus1. vol 1, Available at: http:\/\/aacrjournals.org\/cancerres\/article-pdf\/26\/7_Part_1\/1448\/2381122\/cr0267p11448.pdf (Accessed 10 November 2024)."},{"issue":"4","key":"10.1016\/j.ogc.2025.05.004_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/bdrb.20123","article-title":"NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea","volume":"80","author":"Liebelt","year":"2007","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"issue":"10","key":"10.1016\/j.ogc.2025.05.004_bib21","first-page":"1046","article-title":"Exposure to hydroxyurea and pregnancy outcomes in patients with sickle cell anemia","volume":"101","author":"Ballas","year":"2009","journal-title":"J Natl Med Assoc"},{"issue":"5","key":"10.1016\/j.ogc.2025.05.004_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/phar.2793","article-title":"Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: current evidence and knowledge gaps","volume":"43","author":"Dong","year":"2023","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.ogc.2025.05.004_bib23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ajh.26495","article-title":"Pregnancy outcomes with hydroxyurea use in women with sickle cell disease","volume":"97","author":"Kroner","year":"2022","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.ogc.2025.05.004_bib24","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/bjh.15270","article-title":"Risk factors for vitamin D deficiency in sickle cell disease","volume":"181","author":"Han","year":"2018","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.ogc.2025.05.004_bib25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0022-5347(05)65841-7","article-title":"Genitourinary complications of sickle cell disease","volume":"166","author":"Bruno","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.ogc.2025.05.004_bib26","unstructured":"Sickle Cell Disease: managing acute painful episodes in hospital clinical guideline, Available at: www.nice.org.uk\/guidance\/cg143 (Accessed 10 November 2024), 2012."},{"key":"10.1016\/j.ogc.2025.05.004_bib27","unstructured":"Evidence-Based Management of Sickle Cell Disease: Expert Panel Report, 2014. National Heart, Lung and Blood Institute. 2014, Available at: https:\/\/www.nhlbi.nih.gov\/sites\/default\/files\/media\/docs\/Evd-Bsd_SickleCellDis_Rep2014.pdf (Accessed 10 November 2024)."},{"year":"2021","series-title":"Addressing sickle cell disease","author":"McCormick","key":"10.1016\/j.ogc.2025.05.004_bib28"},{"issue":"2","key":"10.1016\/j.ogc.2025.05.004_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Adv"},{"issue":"16","key":"10.1016\/j.ogc.2025.05.004_bib30","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1182\/bloodadvances.2024012923","article-title":"Prophylactic exchange transfusion in sickle cell disease pregnancy: a TAPS2 feasibility randomized controlled trial","volume":"8","author":"Oteng-Ntim","year":"2024","journal-title":"Blood Adv"},{"issue":"9870","key":"10.1016\/j.ogc.2025.05.004_bib31","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(12)61726-7","article-title":"The transfusion alternatives preoperatively in sickle cell disease (TAPS) study: a randomised, controlled, multicentre clinical trial","volume":"381","author":"Howard","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ogc.2025.05.004_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/AOG.0000000000004986","article-title":"Association of sickle cell disease with severe maternal morbidity","volume":"141","author":"Ha","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.ogc.2025.05.004_bib33","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/ajh.27045","article-title":"Pregnancy-related thromboembolism in women with sickle cell disease: an analysis of National Medicaid Data","volume":"98","author":"Agarwal","year":"2023","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.ogc.2025.05.004_bib34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/01.AOG.0000172428.78411.b0","article-title":"Incidence and risk factors for stroke in pregnancy and the puerperium","volume":"106","author":"James","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"15","key":"10.1016\/j.ogc.2025.05.004_bib35","article-title":"The association between sickle cell disease and postpartum severe maternal morbidity","volume":"41","author":"Poliektov","year":"2024","journal-title":"Am J Perinatol"},{"issue":"17","key":"10.1016\/j.ogc.2025.05.004_bib36","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1080\/14767058.2019.1671333","article-title":"Inpatient mortality and postpartum readmission rates in sickle cell disease pregnancies: a multistate analysis, 2007-2014","volume":"34","author":"Bae","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"13","key":"10.1016\/j.ogc.2025.05.004_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/nu15132822","article-title":"Knowledge gaps and current evidence regarding breastfeeding issues in mothers with chronic diseases","volume":"15","author":"Sokou","year":"2023","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.ogc.2025.05.004_bib38","first-page":"552","article-title":"Women with sickle cell disease report low knowledge and use of long acting reversible contraception","volume":"113","author":"Pecker","year":"2021","journal-title":"J Natl Med Assoc"},{"issue":"2","key":"10.1016\/j.ogc.2025.05.004_bib39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.contraception.2010.06.017","article-title":"Hormonal contraception use and pregnancy in adolescents with sickle cell disease: analysis of Michigan Medicaid claims","volume":"83","author":"O\u2019Brien","year":"2011","journal-title":"Contraception (Stoneham)"},{"issue":"4","key":"10.1016\/j.ogc.2025.05.004_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.ogc.2025.05.004_bib41","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jpeds.2020.02.002","article-title":"Hydroxyurea exposure in lactation: a pharmacokinetics study (HELPS)","volume":"222","author":"Ware","year":"2020","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.ogc.2025.05.004_bib42","first-page":"163","article-title":"Opioid utilization by pregnant women with sickle cell disease and the risk of neonatal abstinence syndrome","volume":"110","author":"Nnoli","year":"2018","journal-title":"J Natl Med Assoc"},{"issue":"3","key":"10.1016\/j.ogc.2025.05.004_bib43","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1055\/s-0039-1700865","article-title":"Neonatal abstinence syndrome among infants born to mothers with sickle cell hemoglobinopathies","volume":"37","author":"Brown","year":"2020","journal-title":"Am J Perinatol"},{"issue":"1","key":"10.1016\/j.ogc.2025.05.004_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0020-7292(90)90649-6","article-title":"Sickle trait and its association with birthweight and urinary tract infections in pregnancy","volume":"33","author":"Baill","year":"1990","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"10.1016\/j.ogc.2025.05.004_bib46","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.ajog.2005.11.022","article-title":"Bacteriuria in pregnant women with sickle cell trait","volume":"194","author":"Thurman","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2025.05.004_bib47","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2147\/JBM.S477507","article-title":"Newer modalities and updates in the management of sickle cell disease: a systematic review","volume":"15","author":"Patel","year":"2024","journal-title":"J Blood Med"},{"issue":"10","key":"10.1016\/j.ogc.2025.05.004_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/cells13100800","article-title":"CRISPR-based gene therapies: from preclinical to clinical treatments","volume":"13","author":"Laurent","year":"2024","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.ogc.2025.05.004_bib50","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1097\/MS9.0000000000002409","article-title":"FDA approval of Casgevy and Lyfgenia: a dual breakthrough in gene therapies for sickle cell disease","volume":"86","author":"Rahmat","year":"2024","journal-title":"Ann Med Surg"},{"issue":"8","key":"10.1016\/j.ogc.2025.05.004_bib51","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1097\/MS9.0000000000002146","article-title":"Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR\/Cas9 gene therapy for sickle cell disease","volume":"86","author":"Singh","year":"2024","journal-title":"Ann Med Surg"},{"issue":"10","key":"10.1016\/j.ogc.2025.05.004_bib52","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1097\/MS9.0000000000002478","article-title":"CRISPR\/Cas9 in the treatment of sickle cell disease (SCD) and its comparison with traditional treatment approaches: a review","volume":"86","author":"Tariq","year":"2024","journal-title":"Ann Med Surg"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985452500021X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985452500021X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:33:46Z","timestamp":1754339626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985452500021X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S088985452500021X"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2025.05.004","relation":{},"ISSN":["0889-8545"],"issn-type":[{"type":"print","value":"0889-8545"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sickle Cell Disease and Other Causes of Anemia","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2025.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}